The importance of robust pharmaceutical storage is only set to increase as personalized medicine, cell therapies, and complex biologics become...
Freepix image[/caption]
Receiving a diagnosis of multiple sclerosis (MS) can be a life-altering event, bringing with it many questions about the future. MS is a condition of the central nervous system that disrupts communication between the brain and the body. Its effects vary widely from person to person, but recent progress in medical science offers more hope and better outcomes than ever before. The focus of care has expanded from simply managing symptoms to actively slowing the condition's progression and improving overall quality of life.
Modern approaches to managing MS have transformed what it means to live with the condition. With a growing range of therapies, people with MS now have more opportunities to maintain their independence and continue participating in the activities they enjoy. These developments reflect a deeper recognition of how the disease works, leading to more targeted and convenient treatment plans.
Victoria Bethel[/caption]
MedicalResearch.com Interview with:
Victoria Bethel, MSN
Department of Public Administration and Policy
University of Georgia, Athens
MedicalResearch.com: What is the background for this study?
Response: From the same pool of commercially insured patients, we found that cannabis dispensary openings were associated with reduced opioid prescribing among patients with non-cancer pain.
For this study, we examined whether cannabis dispensary openings were also associated with reduced opioid prescribing among commercially insured patients who do have a cancer diagnosis.
Similar to patients without cancer, we estimated reductions in opioid prescribing after medical and recreational cannabis dispensaries open. These findings may suggest that patients who experience cancer pain are able to manage their pain with cannabis instead of requiring opioids, although we cannot directly observe substitution.
Photo by Raymond Petrik:[/caption]
The health of your skin is often considered an external issue. However, your skin’s condition can reflect what’s happening inside your body, particularly in relation to your diet. In recent years, research has highlighted the importance of nutrition in maintaining healthy skin. Whether you are dealing with acne, eczema, or aging skin, what you eat plays a crucial role in its appearance and function.
Understanding how food impacts your skin can be the key to better skin health and effective management of skin conditions. Let’s dive into the science of diet and skin health and explore how specific nutrients can affect your complexion.
Photo by Ivan S[/caption]
Groundbreaking discoveries are happening every day in labs around the world, yet most people can't access or understand this vital information. The gap between scientific research and public understanding is wider than most researchers think.
When scientists struggle to communicate their findings effectively, important research gets buried in academic journals where it collects dust instead of making an impact. Meanwhile, the public misses out on knowledge that could improve their lives, inform their decisions and shape their understanding of the world.
Whether you're a researcher, science communicator or educator, making complex information accessible can amplify your impact and ensure your work reaches the people who need it most.
Prof. Kelleher[/caption]
Ian Kelleher PhD, MB BCh BAO (Medicine)
Professor of Child and Adolescent Psychiatry
Academy of Medical Sciences Professor
Institute for Neuroscience and Cardiovascular Research
University of Edinburgh
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Schizophrenia is a severe mental illness associated with hallucinations, delusions and a marked decline in functioning. It usually begins in adulthood, in the 20s, but we know from recent research that as many as half of all individuals who develop schizophrenia had attended child and adolescent psychiatry services earlier in life for other mental health problems. That’s exciting because it suggests: maybe there’s something we could do to reduce risk of schizophrenia in adolescent psychiatry services. But, at present, we don’t have evidence that any intervention reduces schizophrenia risk in this clinical population.
Lots of researchers are interested in the antibiotic doxycycline, and the structurally similarly minocycline, because it has potential neuroprotective effects. It crosses the blood brain barrier and seems to reduce inflammation and apoptosis (or programmed cell death). We think that excessive synaptic pruning may play a key role in the development of schizophrenia. In laboratory studies, doxycycline seems to reduce the level of synaptic pruning by its effect on the immune system. Some research suggests that even low dose exposure to doxycycline may lead to long-term effects in “dampening down” activity by microglia, the brain’s resident macrophages, which are central to the process of synaptic pruning.
Freepix image[/caption]
Are you still battling acne in your 30s, 40s, or beyond? Adult acne presents unique challenges that differ from adolescent breakouts, manifesting as inflammatory papules, pustules, comedones, and sometimes painful cystic lesions along the jawline, chin, and lower face. Hormonal fluctuations, stress-induced cortisol elevation, and compromised skin barrier function create a complex treatment landscape requiring targeted interventions. Dermatologists approach adult acne through combination therapies addressing both active lesions and underlying triggers while preventing post-inflammatory hyperpigmentation common in mature skin.
If you’re struggling with persistent acne that overlaps with sensitivity or eczema, consulting the best dermatologist in Singapore for eczema can help you receive a more holistic and tailored approach — balancing acne control with skin barrier repair for long-term skin health.
Photo by Husna Miskandar on Unsplash[/caption]
In the field of applied behavior analysis (ABA), you will often see the qualifications “RBT” and “BCBA.” While both play important roles in behaviour-analytic services, they differ significantly in terms of education, responsibilities, autonomy, and career trajectory.
For those preparing to enter the field or advance their credentials, using an RBT mock exam can be an excellent way to test your knowledge, identify areas for improvement, and build confidence before certification. Understanding these differences is essential if you’re considering entering the field, either as a direct service provider or a supervisor/analyst.
Photo by Karola G[/caption]
Medical documentation has always been one of those chores nobody really enjoys. Hours typing notes. Filling out charts. Updating records. All while patients wait, shifts keep rolling, and stress quietly creeps in.
AI-powered transcription is slowly changing that. Quietly, almost invisibly. Tasks that used to feel like a slog are now happening faster, cleaner, and honestly, a lot less painfully.
Speed Without Sacrificing Accuracy
The biggest win? Speed. A doctor can dictate notes while seeing a patient. Minutes later, a clean transcript pops up. No more sitting at a computer after every appointment. No more juggling files.
But speed alone isn’t enough. Accuracy is huge. One wrong number. One misheard symptom. And suddenly, the stakes are high. Modern AI transcription tools are actually pretty impressive. They catch tricky medical terms, common abbreviations, and sometimes even rival human transcriptionists.
Some systems will even flag unclear words in real-time — little nudges that save headaches later. The mix of speed and accuracy? That’s what makes them genuinely useful. Notes happen almost automatically, letting clinicians focus on what really matters: patients.
Breaking Language Barriers
Healthcare doesn’t stop at borders. Clinics see patients from all sorts of backgrounds. Traditionally, that meant delays, miscommunication, and guesswork (not ideal).
AI transcription is changing that. Some platforms even handle german voice to text & translate. A doctor can speak in German, and the system handles transcription and translation instantly.
It’s not just faster. Notes are clearer. Staff don’t have to scramble to interpret them. Communication across languages actually improves. Multilingual transcription isn’t just a nice feature anymore — it’s becoming essential in modern healthcare.
Dr. Bian Jiang[/caption]
Jiang Bian, PhD
Associate Dean of Data Science
Walther and Regenstrief Professor of Cancer Informatics
Professor of Biostatistics & Health Data Science
Adjunct Professor, Biomedical Engineering and Informatics
Chief Data Scientist, Regenstrief Institute
Chief Data ScientistCustomize & Schedule Social Media Posts
Indiana University Health
[caption id="attachment_71230" align="alignleft" width="125"]
Dr. Serena Guo[/caption]
Serena Jingchuan Guo, MD PhD
Assistant Professor
Department of Pharmaceutical Outcomes and Policy
University of Florida College of Pharmacy
[caption id="attachment_71231" align="alignleft" width="125"]
Dr. Hao Dai[/caption]
Hao Dai, PhD
Postdoctoral Fellow
Department of Biostatistics & Health Data Science
Indiana University School of Medicine
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Obesity and type 2 diabetes are both known to increase the risk of several cancers. Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have become very popular for both glycemic control and weight loss, but their long-term effects on cancer risk are still unclear. Using a large real-world dataset, we emulated a target trial comparing more than 43,000 GLP-1RA users to matched non-users.
We found that GLP-1RA use was associated with a significantly lower overall cancer risk.
Unsplash image[/caption]
Understanding how the brain functions has always been one of science’s most fascinating and complex challenges. Today, advanced technologies like quantitative electroencephalography (QEEG) are making it possible to visualize brain activity in ways that were once unimaginable. Known simply as brain mapping, this innovative process offers a window into the intricate electrical patterns that define how we think, feel, and behave. By measuring and analyzing brainwave activity, QEEG is revolutionizing the way medical professionals diagnose and treat a wide range of neurological and psychological conditions.
Dr. Dehghani[/caption]
MedicalResearch.com Interview with:
Ali Dehghani, DO
Department of Medicine
University Hospitals Cleveland Medical Center / Case Western Reserve University
Presenting Author, IDWeek 2025
MedicalResearch.com: What is the background for this study?
Response: Shingles (herpes zoster) is caused by reactivation of the varicella-zoster virus, which can inflame blood vessels and the nervous system. Evidence over the past decade has linked shingles to higher risks of heart attack, stroke, and dementia—but it was unclear whether the shingles vaccine might lessen those long-term effects.
[caption id="attachment_71061" align="aligncenter" width="500"] CDC PHIL Image[/caption]
MedicalResearch.com: What are the main findings?
Response: Using data from over 100 U.S. health systems, we followed adults age 50 and older for up to five years. We found that people who developed shingles had a 20–30% higher risk of cardiovascular events, vascular dementia, and death compared with similar adults without shingles.
Those who had received the recombinant zoster vaccine (Shingrix) before their infection had substantially lower long-term risks—about 25% fewer major cardiac events, 40% lower early mortality, and nearly 50% less vascular dementia over time.
Chris Church[/caption]
MedicalResearch.com Interview with:
Chris Church MPT
Director, Gait & Motion Analysis Laboratory
Nemours duPont Hospital for Children
MedicalResearch.com: What is the background for this study? Would you briefly describe the condition of clubfoot and arthrogryposis?
Response: Clubfoot is a congenital foot deformity in which the child is born with their foot (or feet) are stiff and in position with the foot pointing down (equinus) and in (inverted). Idiopathic clubfoot is a condition in which these children only have issues with their feet. Arthrogryposis is a condition in which children have contractures in multiple parts of their body. Children with Arthrogryposis often have clubfeet that are tighter and more difficult to treat than the more common idiopathic type.
Idiopathic clubfoot is effectively corrected with a conservative treatment known as the Ponseti method. Recent studies have shown successful short-term correction using Ponseti treatment in the stiffer clubfoot associated with arthrogryposis, but there are few studies analyzing long-term results. This study compares outcomes of the Ponseti method in 10-year-old children with idiopathic clubfoot and clubfoot associated with arthrogryposis.
MedicalResearch.com: Would you describe the Ponseti method? Does it require specialized or complicated training to implement treatment?
Response: Clubfoot was treated with surgery in the past. Now we use a more conservative treatment that is provided by pediatric orthopedic surgeons and physical therapists. The Ponseti method involved serial casting in infancy, Achillies tenotomies, and prolonged use of bracing during sleep until age 5 years.
[caption id="attachment_71050" align="alignleft" width="300"]
Clubfoot
Clubfoot
Dr. Weintraub[/caption]
Michael A. Weintraub, MD
Clinical Assistant Professor
Department of Medicine
NYU Grossman School of Medicine
MedicalResearch.com: What is the background for this study?
Response: The study addresses a critical knowledge gap in diabetes
management for dialysis patients.
Of the 808,000 people on dialysis in the United States,
approximately 60% have diabetes and would be
eligible for GLP-1 receptor agonists (GLP-1 RAs).
However, these medications have not been well-studied in this population because
dialysis dependence is frequently an exclusion criterion in clinical
trials.
The best recovery outcomes are achievable when holistic therapies are seamlessly integrated with evidence-based behavioral interventions. Treatment centers are increasingly...
Dr. Jiyoung Ahn[/caption]
MedicalResearch.com Interview with:
Jiyoung Ahn, PhD
Professor of Population Health, NYU Grossman School of Medicine
Associate Director for Population Science, NYU Perlmutter Cancer Center
NYU Langone Health
New York, NY 10016
MedicalResearch.com: What is the background for this study?
Response: About 10 years ago. we reported that people with poor oral health seem to have a greater risk of pancreatic cancer development. We suspected that this could be due to oral microbiota. More recently, animal studies, by other groups, showed that bacteria from the mouth can actually travel through saliva into the pancreas. But we didn’t know which exact species of bacteria or fungi might be involved in pancreas cancer development. We therefore conducted this large human study to examine the oral microbiome — including whole bacteria and fungi profiles in the mouth, and to see which bacteria and fungal taxa are associated with subsequent risk of pancreatic cancer development.
Dr. King[/caption]
Brett King, MD, PHD
Dr. King was named an American Academy of Dermatology (AAD) “Patient Care Hero”
for his work treating patients with severe alopecia areata
Dermatology Physicians of Connecticut
Fairfield, Connecticut
MedicalResearch.com: What is the background for this study? Would you briefly explain the condition of Alopecia Areata?
Response: Alopecia Areata (AA), an autoimmune form of hair loss, is common and its treatment has been revolutionized in the past ~3 years with approvals of 3 JAK inhibitors, bariticinib, ritlecitinib and deuruxolitinib. Prior to these approvals, off label treatments included the JAK inhibitors tofacitinib and ruxolitinib.
In a world of multiple treatments, especially when those treatments belong to the same medicine class, the question arises “If patients do not achieve treatment success with one medicine, might they achieve treatment success with another one?”
Dr. Joshi[/caption]
Gagan Joshi, MD
Director, The Alan & Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorder
Associate Director, The Pediatric Psychopharmacology Research Program
Associate Program Director, MGH Fellowship in Autism Spectrum Disorder
Rovee Endowed Chair in Child Psychiatry
Massachusetts General Hospital
Associate Professor of Psychiatry
Harvard Medical School
MedicalResearch.com: What is the background for this study?
Response: Intellectually capable individuals with autism often face significant challenges in social functioning, yet pharmacologic treatments specifically targeting social impairments are lacking. Our prior neuroimaging research identified abnormally elevated brain glutamate levels in intellectually capable youth with autism, suggesting a potential neurochemical pathway underlying social difficulties. Based on these findings, we examined the effects of memantine—a glutamate-modulating medication—for the treatment of autism.
Freepix image[/caption]
Cancer is one of the most complex and heterogeneous diseases known to medicine. Tumors can differ not only between patients but also within a single individual, with subclones evolving over time and influencing how the disease progresses or responds to treatment. Next-generation sequencing (NGS) has become a critical tool in oncology, helping researchers and clinicians unravel this complexity at the molecular level.
By analyzing DNA and RNA at high resolution, NGS enables the detection of mutations, copy number changes, gene fusions, and expression patterns that shape tumor biology. This information provides insight into cancer drivers, mechanisms of resistance, and therapeutic targets. Importantly, it also supports precision medical oncology, where treatments are guided by the specific molecular features of a patient’s tumor rather than by one-size-fits-all approaches.
Dr. Minji Jung[/caption]
Minji Jung PharmD, PhD
Postdoctoral Research Fellow in Epidemiology
Department of Urology
Stanford University Medical Center
Stanford, CA
MedicalResearch.com: What is the background for this study?
Response: Hypertension is a well-established risk factor for kidney cancer, and previous studies have suggested potential links between antihypertensive medications and kidney cancer risk. However, distinguishing the effects of the medications from those of hypertension itself has been challenging. Our meta-analysis systematically evaluated different classes of antihypertensive drugs while accounting for hypertension.
Dr. Baccarelli[/caption]
Statement from Andrea Baccarelli, MD, PhD
Dean of the Faculty
Professor of Environmental Health
Harvard T.H. Chan School of Public Health
Colleagues and I recently conducted a rigorous review, funded by a grant from the National Institutes of Health (NIH), of the potential risks of acetaminophen use during pregnancy. We reviewed 46 previously published human studies worldwide.
We found evidence of an association between exposure to acetaminophen during pregnancy and increased incidence of neurodevelopmental disorders in children. This association is strongest when acetaminophen is taken for four weeks or longer.
Longevity science has a long history, dating back to the 1900s when people practiced gerontology, the scientific study of aging. In this era, scientists embarked on a study of the mortality and aging patterns in different organisms. Through the 20th century and early 21st century, aging research evolved into what we now know as longevity science, a science that goes beyond extending lifespan. Longevity science stands out for its specific focus on extending healthspan – the period of life we spend in good health.
This branch of science has birthed various interventions to help us in the race against time. These include caloric restriction, genetic research, and biomarker-driven personalized medicine. And now, with the recent launch of the Longevity World Cup, Adam Ficsor is fueling the discovery of even more techniques to reverse aging.
Infection control works best when it becomes part of everyday culture. That means small actions repeated thousands of times—hands washed,...
Photo by Kampus Production[/caption]
Dr. Kamel[/caption]
MedicalResearch.com Interview with:
Ibrahim Kamel, MD, MHA
Boston Medical Center – Brighton
Clinical Instructor
Boston Medical Center
Boston University
MedicalResearch.com: What is the background for this study?
Response: Cannabis use carries risk for developing Type 2 diabetes. It is important for physicians to screen for the use of cannabis to better understand each patients risk.
MedicalResearch.com: What are the main findings?
Response: Clinically physicians should screen for and council on the risk of cannabis use. People should know what is the risk in the substances they use and make the choice that they feel is right. 
Photo by Artem Podrez[/caption]
Medical research labs are environments where innovation and discovery thrive. However, they also involve risks that can compromise the safety of researchers and the integrity of experiments if not properly managed. Implementing essential safety practices is not optional; it is a cornerstone of responsible research. Below, we outline key measures every medical research lab should consistently carry out.
Source[/caption]